The latter obtained an AUROC of 0.811 [202] for diagnosing NASH, a superior value compared with that of CK-18 and also a 7.2-fold change in NASH vs. controls [203], suggesting its promising potential as a noninvasive biomarker [204]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.